» Articles » PMID: 35843941

The Association of Vitamin D Binding Protein Levels and Genotypes with Type 1 Diabetes in the Black South African Population

Overview
Publisher Biomed Central
Specialty Endocrinology
Date 2022 Jul 17
PMID 35843941
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin D deficiency and the vitamin D pathway have previously been associated with type 1 diabetes (T1D). The majority of vitamin D is transported through the blood bound to the vitamin D binding protein (VDBP). Two polymorphisms in the VDBP gene (rs4588 and rs7041) result in different VDBP variants and have been associated with T1D, however the results are not consistent. The association of VDBP levels and its polymorphisms with T1D have not been investigated in the black South African population. Therefore, this study aimed to determine whether rs4588, rs7041 or serum VDBP levels were associated with T1D in this population.

Methods: Participants with type 1 diabetes and controls were recruited from the greater Johannesburg area, South Africa. Participants were genotyped for rs4588 and rs7041 using PCR-RFLP and serum VDBP levels were determined by ELISA.

Results: There was no difference in VDBP allelic or genotypic frequencies between participants with T1D and controls (rs4588 C allele frequency 0.92 vs. 0.94; p = 0.390 and rs7041 T allele frequency 0.95 vs. 0.95; p = 0.890). In univariate analysis, the rs4588 CC genotype was associated with increased serum VDBP levels, however, this association was lost with multivariate analysis. The VDBP genotypes were not associated with any other study variables. In logistic regression analysis, higher VBDP levels were associated with T1D (OR: (95% CI): 6.58 (1.45-29.9); p = 0.015), and within a linear regression analysis, T1D disease status was found to be associated with 0.044 mg/ml higher VDBP levels (p = 0.028).

Conclusions: These data suggest that serum VDBP levels are positively associated with the presence of T1D in the African population. Whether VDBP lies in the causal pathway or its elevation is an effect of T1D is uncertain and requires further investigation.

Citing Articles

Indian ASD probands with 25(OH)D and vitamin D binding protein deficiency exhibited higher severity.

Shom S, Saha S, Chatterjee M, Sinha S, Mukhopadhyay K Sci Rep. 2024; 14(1):19242.

PMID: 39164358 PMC: 11336207. DOI: 10.1038/s41598-024-70188-x.


Vitamin D-Binding Protein and the Role of its Gene Polymorphisms in the Mortality of Sepsis Patients.

Kahar L, Yusrawati Y, Jamsari J, Maskoen T, Aribowo K, Monika Sari W Acta Med Acad. 2024; 52(3):212-220.

PMID: 38407088 PMC: 10945317. DOI: 10.5644/ama2006-124.428.

References
1.
Constans J, Viau M . Group-specific component: evidence for two subtypes of the Gc1 gene. Science. 1977; 198(4321):1070-1. DOI: 10.1126/science.73222. View

2.
Purohit S, Sharma A, Zhi W, Bai S, Hopkins D, Steed L . Proteins of TNF-α and IL6 Pathways Are Elevated in Serum of Type-1 Diabetes Patients with Microalbuminuria. Front Immunol. 2018; 9:154. PMC: 5797770. DOI: 10.3389/fimmu.2018.00154. View

3.
Lauridsen A, Vestergaard P, Hermann A, Brot C, Heickendorff L, Mosekilde L . Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int. 2005; 77(1):15-22. DOI: 10.1007/s00223-004-0227-5. View

4.
Powe C, Evans M, Wenger J, Zonderman A, Berg A, Nalls M . Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med. 2013; 369(21):1991-2000. PMC: 4030388. DOI: 10.1056/NEJMoa1306357. View

5.
Thrailkill K, Jo C, Cockrell G, Moreau C, Fowlkes J . Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency?. J Clin Endocrinol Metab. 2010; 96(1):142-9. PMC: 3038488. DOI: 10.1210/jc.2010-0980. View